FDA Finds No New Problems With Zyprexa Relprevv After Safety Review
An FDA review has determined that Zyprexa Relprevv needs no new label warning following two patient deaths.
Tag Archives: Zyprexa Relprevv
-
-
Long-Acting Zyprexa Relprevv Deaths Result in FDA Warning
The FDA has launched an investigation into Zyprexa Relprevv, a long-acting antipsychotic, after two patients were found dead days after receiving injections.
